Women on the Verge of a Clinical Breakthrough
Women’s health used to be considered solely in terms of maternal and reproductive health. Not anymore. As our knowledge of the basic biological differences between the sexes grows, it’s clear we must take action to ensure women are represented throughout the drug development process.
Traditionally, women – and particularly women from ethnic minorities – have been under-represented in clinical trials. Until relatively recently, the prevailing belief was that a medicine could be tested on white men and would work similarly in everyone else. We now know that is not the case, and despite efforts from regulators and advocacy groups over the past decade, change has been slow.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine